tiprankstipranks

Pacira named a top pick for 2024 at H.C. Wainwright

H.C. Wainwright names Pacira BioSciences a top pick for 2024 and reiterates a Buy rating on the shares with a $57 price target. The stock is trading near 10-year lows and near all-time low forward multiples, the analyst tells investors in a research note. The firm believes there is a “compelling disconnect” between the current valuation and the company’s “robust cash flows, low leverage, and likely a very long exclusivity runway.”

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on PCRX:

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue